We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-3.18%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.57B
AUM Growth
-$118M
Cap. Flow
-$42.5M
Cap. Flow %
-2.71%
Top 10 Hldgs %
17.86%
Holding
854
New
57
Increased
321
Reduced
405
Closed
55
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EEFT icon
551
Euronet Worldwide
EEFT
$2.58B
$440K 0.03%
5,543
-1,086
-16% -$101K
PSI icon
552
Invesco Semiconductors ETF
PSI
$2.59B
$440K 0.03%
10,270
-200
-2% -$8.97K
D icon
553
Dominion Energy
D
$60.1B
$436K 0.03%
9,762
-5,397
-36% -$268K
HAS icon
554
Hasbro
HAS
$13.5B
$435K 0.03%
6,584
-344
-5% -$22.8K
TRU icon
555
TransUnion
TRU
$15B
$435K 0.03%
6,058
-65
-1% -$5.1K
BDJ icon
556
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.75B
$433K 0.03%
56,896
-454
-0.8% -$3.63K
HCC icon
557
Warrior Met Coal
HCC
$5.09B
$433K 0.03%
8,473
-16
-0.2% -$672
STLD icon
558
Steel Dynamics
STLD
$37.7B
$432K 0.03%
4,032
-63
-2% -$6.56K
DCPH
559
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$432K 0.03%
33,942
-6,701
-16% -$92.4K
IBB icon
560
iShares Biotechnology ETF
IBB
$9.85B
$429K 0.03%
3,510
BRX icon
561
Brixmor Property Group
BRX
$9.1B
$427K 0.03%
20,550
-59
-0.3% -$1.31K
OZK icon
562
Bank OZK
OZK
$5.64B
$425K 0.03%
11,471
+480
+4% +$19.4K
RNAM
563
DELISTED
Avidity Biosciences
RNAM
$422K 0.03%
66,220
+31,277
+90% +$269K
GLD icon
564
SPDR Gold Trust
GLD
$144B
$421K 0.03%
2,456
HNI icon
565
HNI Corp
HNI
$3.51B
$420K 0.03%
12,130
-5,551
-31% -$171K
STX icon
566
Seagate
STX
$200B
$419K 0.03%
6,354
-5,012
-44% -$323K
TREX icon
567
Trex
TREX
$4.96B
$418K 0.03%
6,790
CMC icon
568
Commercial Metals
CMC
$7.98B
$417K 0.03%
8,445
-121
-1% -$6.58K
FFC
569
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$784M
$417K 0.03%
32,138
+11,467
+55% +$155K
NGG icon
570
National Grid
NGG
$81.5B
$416K 0.03%
7,280
-186
-2% -$11.2K
VRDN icon
571
Viridian Therapeutics
VRDN
$2.62B
$416K 0.03%
27,112
+12,807
+90% +$244K
LEA icon
572
Lear
LEA
$8.06B
$414K 0.03%
3,083
+55
+2% +$7.96K
AGCO icon
573
AGCO
AGCO
$7.04B
$413K 0.03%
3,494
+679
+24% +$86.3K
AMPH icon
574
Amphastar Pharmaceuticals
AMPH
$841M
$411K 0.03%
8,928
+2,050
+30% +$112K
HBNC icon
575
Horizon Bancorp
HBNC
$1.05B
$410K 0.03%
38,420
-1,875
-5% -$21K

Similar funds

Hennion & Walsh Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hennion & Walsh Asset Management held 854 positions worth $1.57B, down 7% from $1.69B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q3 2023 filing shows 57 new, 321 increased, 405 reduced and 55 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q3 2023 buy was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M.
  • Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q3 2023, an estimated $2.51M increase.
  • Hennion & Walsh Asset Management's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $20.5M.
  • Hennion & Walsh Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $4.42M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.57B portfolio in Q3 2023.
  • Hennion & Walsh Asset Management opened 57 new positions and closed 55 in Q3 2023.
  • Hennion & Walsh Asset Management's portfolio value fell 7% quarter-over-quarter to $1.57B.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.